Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease
Summary: Clinical application of stem cell derivatives requires clinical-grade cells and sufficient preclinical proof of safety and efficacy, preferably in primates. We previously successfully established a clinical-grade human parthenogenetic embryonic stem cell (hPESC) line, but the suitability of...
Main Authors: | Yu-Kai Wang, Wan-Wan Zhu, Meng-Hua Wu, Yi-Hui Wu, Zheng-Xin Liu, Ling-Min Liang, Chao Sheng, Jie Hao, Liu Wang, Wei Li, Qi Zhou, Bao-Yang Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-07-01
|
Series: | Stem Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213671118302273 |
Similar Items
-
Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease
by: Rodolfo Gonzalez, et al.
Published: (2016-11-01) -
Antimicrobial Use and Resistance in Zoonotic Bacteria Recovered from Nonhuman Primates
by: Kim, Jeffrey
Published: (2016) -
Recovering stimulus locations using populations of eye-position modulated neurons in dorsal and ventral visual streams of nonhuman primates
by: Anne B Sereno, et al.
Published: (2014-03-01) -
Pruriception and neuronal coding in nociceptor subtypes in human and nonhuman primates
by: Amanda Klein, et al.
Published: (2021-04-01) -
Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives
by: F. Wianny, et al.
Published: (2017-10-01)